Literature DB >> 22430715

Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Sayna Norouzi1, Asghar Aghamohammadi, Setareh Mamishi, Sergio D Rosenzweig, Nima Rezaei.   

Abstract

Primary immunodeficiency diseases (PIDs) are a group of inherited disorders, characterized by defects of the immune system predisposing individuals to variety of manifestations, including recurrent infections and unusual vaccine complications. There are a number of PIDs prone to Bacillus Calmette-Guérin (BCG) complications. This review presents an update on our understanding about the BCGosis-susceptible PIDs, including severe combined immunodeficiency, chronic granulomatous disease, and Mendelian susceptibility to mycobacterial diseases.
Copyright © 2012 The British Infection Association. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22430715      PMCID： PMC4792288          DOI： 10.1016/j.jinf.2012.03.012

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  147 in total

1.  Clinical spectrum of X-linked hyper-IgM syndrome.

Authors:  J Levy; T Espanol-Boren; C Thomas; A Fischer; P Tovo; P Bordigoni; I Resnick; A Fasth; M Baer; L Gomez; E A Sanders; M D Tabone; D Plantaz; A Etzioni; V Monafo; M Abinun; L Hammarstrom; T Abrahamsen; A Jones; A Finn; T Klemola; E DeVries; O Sanal; M C Peitsch; L D Notarangelo
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

Review 2.  SCID due to ZAP-70 deficiency.

Authors:  M E Elder
Journal:  J Pediatr Hematol Oncol       Date:  1997 Nov-Dec       Impact factor: 1.289

3.  Accounting for genetic heterogeneity in homozygosity mapping: application to Mendelian susceptibility to mycobacterial disease.

Authors:  Audrey V Grant; Stéphanie Boisson-Dupuis; Eléonore Herquelot; Ludovic de Beaucoudrey; Orchidée Filipe-Santos; Daniel K Nolan; Jacqueline Feinberg; Anne Boland; Saleh Al-Muhsen; Ozden Sanal; Yildiz Camcioglu; Ayse Palanduz; Sara Sebnem Kilic; Jacinta Bustamante; Jean-Laurent Casanova; Laurent Abel
Journal:  J Med Genet       Date:  2011-05-14       Impact factor: 6.318

Review 4.  Severe combined immunodeficiency. A model disease for molecular immunology and therapy.

Authors:  Alain Fischer; Françoise Le Deist; Salima Hacein-Bey-Abina; Isabelle André-Schmutz; Geneviève de Saint Basile; Jean-Pierre de Villartay; Marina Cavazzana-Calvo
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

5.  Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.

Authors:  E Jouanguy; S Lamhamedi-Cherradi; F Altare; M C Fondanèche; D Tuerlinckx; S Blanche; J F Emile; J L Gaillard; R Schreiber; M Levin; A Fischer; C Hivroz; J L Casanova
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease.

Authors:  Jacinta Bustamante; Capucine Picard; Claire Fieschi; Orchidée Filipe-Santos; Jacqueline Feinberg; Christian Perronne; Ariane Chapgier; Ludovic de Beaucoudrey; Guillaume Vogt; Damien Sanlaville; Arnaud Lemainque; Jean-François Emile; Laurent Abel; Jean-Laurent Casanova
Journal:  J Med Genet       Date:  2007-02       Impact factor: 6.318

7.  Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease.

Authors:  M Y Köker; K van Leeuwen; M de Boer; F Celmeli; A Metin; T T Ozgür; I Tezcan; O Sanal; D Roos
Journal:  Eur J Clin Invest       Date:  2009-04       Impact factor: 4.686

8.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

9.  An intensive approach to the treatment of disseminated BCG infection in a SCID patient.

Authors:  A Ikincioğullari; F Doğu; E Ciftci; E Unal; M Ertem; I Reisli; S Adiyaman; S T Yildiran; S Erekul; E Babacan
Journal:  Bone Marrow Transplant       Date:  2002-07       Impact factor: 5.483

10.  Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry.

Authors:  Masoud Movahedi; Asghar Aghamohammadi; Nima Rezaei; Nikrad Shahnavaz; Ali Babaei Jandaghi; Abolhasan Farhoudi; Zahra Pourpak; Mostafa Moin; Mohammad Gharagozlou; Davoud Mansouri
Journal:  Int Arch Allergy Immunol       Date:  2004-06-01       Impact factor: 2.749
View more
  46 in total

1.  Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Andrés Obregón-Henao; Elizabeth Creissen; Crystal Shanley; Ian Orme; Diane J Ordway
Journal:  Clin Vaccine Immunol       Date:  2014-11-12

2.  Successful management of cutaneous BCG dissemination in a child affected by SCID and receiving allogeneic hematopoietic stem cell transplant.

Authors:  A Naselli; G Losurdo; S Giardino; G Morreale; C Savioli; E Castagnola
Journal:  Bone Marrow Transplant       Date:  2015-06-29       Impact factor: 5.483

3.  Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome.

Authors:  Yiwa Suksawat; Achara Sathienkijkanchai; Jittima Veskitkul; Orathai Jirapongsananuruk; Nualanong Visitsunthorn; Pakit Vichyanond; Punchama Pacharn
Journal:  J Clin Immunol       Date:  2017-04-20       Impact factor: 8.317

Review 4.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

5.  BCGosis in Infants with Severe Combined ImmunoDeficiency (SCID).

Authors:  Pavani Chitamanni; Jagadeesh Anbazhagan; Narayanan Parameswaran; Saravanakumari Vijayakumar
Journal:  Indian J Pediatr       Date:  2018-02-08       Impact factor: 1.967

Review 6.  Infectious Complications in Patients With Chronic Granulomatous Disease.

Authors:  Nicholas Bennett; Paul J Maglione; Benjamin L Wright; Christa Zerbe
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

7.  Clinical and Molecular Features of Chronic Granulomatous Disease in Mainland China and a XL-CGD Female Infant Patient After Prenatal Diagnosis.

Authors:  Shiyu Wang; Tao Wang; Qingqing Xiang; Min Xiao; Yao Cao; Huan Xu; Shujuan Li; Wen Tian; Xiaodong Zhao; Xuemei Tang; Liping Jiang
Journal:  J Clin Immunol       Date:  2019-08-27       Impact factor: 8.317

8.  Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.

Authors:  Salem Al-Tamemi; Shafiq Ur Rehman Naseem; Nabila Al-Siyabi; Ibtisam El-Nour; Abdulhakim Al-Rawas; David Dennison
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

9.  Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.

Authors:  R F Abu-Arja; B E Gonzalez; M R Jacobs; L Cabral; R Egler; J Auletta; J Arnold; K R Cooke
Journal:  Transpl Infect Dis       Date:  2014-07-04       Impact factor: 2.228

10.  CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.

Authors:  Thais das Neves Fraga Moreira; Maria Isabel de Moraes-Pinto; Beatriz Tavares Costa-Carvalho; Anete Sevciovic Grumach; Lily Yin Weckx
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.